Announcements

We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer epidemiology and prevention in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special Issues is provided below:

“Personalized Preventive Medicine of Oral Cancer”
Guest Editors: Dr. Pierre Saintigny, Dr. Senada Koljenović, Dr. Paolo Bossi and Dr. Jebrane Bouaoud

“The Mechanisms of Physical Activity, Diet, and Body Composition in Cancer Prevention and Control”
Guest Editor: Dr. Justin C. Brown

“Molecular Mechanisms Underlying Cancer Prevention and Intervention with Bioactive Food Components”
Guest Editor: Prof. Dr. Anupam Bishayee

“Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic Alterations”
Guest Editors: Prof. Dr. Hamid Morjani and Prof. Dr. Mohamed Zaiou

“Epidemiology and Biological Features of Melanoma”
Guest Editors: Prof. Dr. Ludwig M. Heindl and Prof. Dr. Jochen Sven Utikal

“Role of Diet in Cancer Prevention and Treatment”
Guest Editors: Prof. Giovanna Caderni and Dr. Giovanna Masala

“Breast Cancer Risk and Prevention”
Guest Editors: Prof. Dr. Tommaso Susini and Prof. Dr. Laura Papi

“Breast Cancer: Risk Factors, Prevention and Early Detection”
Guest Editor: Prof. Antonis Valachis

You are invited to view and submit relevant papers and proposals for some related Special Issues to the journal Cancers at the following links:

• https://www.mdpi.com/journal/cancers;
• https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.

Cancers Editorial Office

We are pleased to announce MDPI’s Transfer Service.

This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.

We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:

1. Select alternative journals on submission.

2. Authors are encouraged to transfer manuscripts to other MDPI journals.

More details about the Transfer Service can be found at the following link:

https://www.mdpi.com/authors/transfer-service

We are pleased to invite you to read the highly cited Special Issues in 2022–2023 related to cancer survivorship and quality of life in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special Issues is provided below.

“Palliative and Supportive Care in Oncology: An Update”
Edited by: Prof. Dr. Marco Cesare Maltoni
Views: 69000+ | Cited by 180+

“Physical Activity and Cancer Care”
Edited by: Dr. Luisa Soares-Miranda
Views: 53000+ | Cited by 120+

“Environmental Carcinogenesis”
Edited by: Dr. Sonika Patial and Prof. Dr. Sonja M. Kessler
Views: 32900+ | Cited by 130+

“Lymphoma Survivorship”
Edited by: Dr. Francesco Merli, Dr. Monica Balzarotti and Dr. Alessandra Tucci
Views: 22900+ | Cited by 50+

“A Model for Improved Care of Patients with Colorectal Cancer – Experience from a Center of Clinical Excellence”
Edited by: Prof. Dr. Torben Frøstrup Hansen and Prof. Dr. Lars Henrik Jensen
Views: 26900+ | Cited by 90+

“The Role of Lifestyle-Related Factors in Cancer Survivorship”
Edited by: Dr. Alina Vrieling and Dr. Renate Maria Winkels
Views: 25500+ | Cited by 80+

“Breast Development and Cancer”
Edited by: Prof. Dr. Martine Berliere and Prof. Christine C. Galant
Views: 40900+ | Cited by 60+

“Cancer-Related Pain”
Edited by: Dr. Wendy H. Oldenmenger and Dr. Evelien J.M. Kuip
Views: 17000+ | Cited by 60+

You are invited to view and submit relevant papers and proposals for some related Special Issues to the journal Cancers at the following links:

• https://www.mdpi.com/journal/cancers;
• https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.

Cancers Editorial Office

May is designated as “Bladder Cancer Awareness Month”, with various global activities that highlight and increase awareness of Bladder Cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of bladder cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

“Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer”
by Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela and Pablo Gajate
Cancers 2023, 15(3), 566; https://doi.org/10.3390/cancers15030566
Available online: https://www.mdpi.com/2072-6694/15/3/566

“Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach”
by Suryadipto Sarkar, Kong Min, Waleed Ikram, Ryan W. Tatton, Irbaz B. Riaz, Alvin C. Silva, Alan H. Bryce, Cassandra Moore, Thai H. Ho, Guru Sonpavde et al.
Cancers 2023, 15(6), 1673; https://doi.org/10.3390/cancers15061673
Available online: https://www.mdpi.com/2072-6694/15/6/1673

“Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy”
by Julieta Afonso, Céline Gonçalves, Marta Costa, Débora Ferreira, Lúcio Santos, Adhemar Longatto-Filho and Fátima Baltazar
Cancers 2023, 15(3), 982. https://doi.org/10.3390/cancers15030982
Available online: https://www.mdpi.com/2072-6694/15/3/982

“Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients”
by Costantino Leonardo, Rocco Simone Flammia, Sara Lucciola, Flavia Proietti, Martina Pecoraro, Bruno Bucca, Leslie Claire Licari, Antonella Borrelli, Eugenio Bologna, Nicholas Landini et al.
Cancers 2023, 15(3), 580; https://doi.org/10.3390/cancers15030580
Available online: https://www.mdpi.com/2072-6694/15/3/580

“Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype”
by Ana Blanca, Antonio Lopez-Beltran, Kevin Lopez-Porcheron, Enrique Gomez-Gomez, Alessia Cimadamore, Andreia Bilé-Silva, Rajan Gogna, Rodolfo Montironi and Liang Cheng
Cancers 2023, 15(7), 2149; https://doi.org/10.3390/cancers15072149
Available online: https://www.mdpi.com/2072-6694/15/7/2149

“RNA-Binding Proteins in Bladder Cancer”
by Yuanhui Gao, Hui Cao, Denggao Huang, Linlin Zheng, Zhenyu Nie and Shufang Zhang
Cancers 2023, 15(4), 1150; https://doi.org/10.3390/cancers15041150
Available online: https://www.mdpi.com/2072-6694/15/4/1150

“Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis”
by Amélie Aboudaram, Léonor Chaltiel, Damien Pouessel, Pierre Graff-Cailleaud, Nicolas Benziane-Ouaritini, Paul Sargos, Ulrike Schick, Gilles Créhange, Elizabeth Cohen-Jonathan Moyal, Christine Chevreau et al.
Cancers 2023, 15(4), 1161; https://doi.org/10.3390/cancers15041161
Available online: https://www.mdpi.com/2072-6694/15/4/1161

“Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial”
by Rodolfo Hurle, Francesco Soria, Roberto Contieri, Pier Paolo Avolio, Stefano Mancon, Massimo Lazzeri, Valentina Bernasconi, Simone Mazzoli, Giuseppe Pizzuto, Matteo De Bellis et al.
Cancers 2023, 15(5), 1618; https://doi.org/10.3390/cancers15051618
Available online: https://www.mdpi.com/2072-6694/15/5/1618

“Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review”
by Farbod Khoraminia, Saul Fuster, Neel Kanwal, Mitchell Olislagers, Kjersti Engan, Geert J. L. H. van Leenders, Andrew P. Stubbs, Farhan Akram and Tahlita C. M. Zuiverloon
Cancers 2023, 15(18), 4518; https://doi.org/10.3390/cancers15184518
Available online: https://www.mdpi.com/2072-6694/15/18/4518

“Development of Deep Learning with RDA U-Net Network for Bladder Cancer Segmentation”
by Ming-Chan Lee, Shao-Yu Wang, Cheng-Tang Pan, Ming-Yi Chien, Wei-Ming Li, Jin-Hao Xu, Chi-Hung Luo and Yow-Ling Shiue
Cancers 2023, 15(4), 1343; https://doi.org/10.3390/cancers15041343
Available online: https://www.mdpi.com/2072-6694/15/4/1343

“The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer”
by Hao Wang, Yanfei Feng, Xiangyi Zheng and Xin Xu
Cancers 2023, 15(4), 1007; https://doi.org/10.3390/cancers15041007
Available online: https://www.mdpi.com/2072-6694/15/4/1007

“Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence”
by Mara Bacchiani, Vincenzo Salamone, Eleana Massaro, Alessandro Sandulli, Riccardo Mariottini, Anna Cadenar, Fabrizio Di Maida, Benjamin Pradere, Laura S. Mertens, Mattia Longoni et al.
Cancers 2023, 15(11), 2951; https://doi.org/10.3390/cancers15112951
Available online: https://www.mdpi.com/2072-6694/15/11/2951

“Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality”
by Simon U. Engelmann, Christoph Pickl, Maximilian Haas, Sebastian Kaelble, Valerie Hartmann, Maximilian Firsching, Laura Lehmann, Miodrag Gužvić, Bas W. G. van Rhijn, Johannes Breyer et al.
Cancers 2023, 15(6), 1778; https://doi.org/10.3390/cancers15061778
Available online: https://www.mdpi.com/2072-6694/15/6/1778

“A Comprehensive Analysis of Immune Response in Patients with Non-Muscle-Invasive Bladder Cancer”
by Guillermo Celada Luis, Eduardo Albers Acosta, Hortensia de la Fuente, Clara Velasco Balanza, Montserrat Arroyo Correas, Nuria Romero-Laorden, Arantzazu Alfranca and Carlos Olivier Gómez
Cancers 2023, 15(5), 1364; https://doi.org/10.3390/cancers15051364
Available online: https://www.mdpi.com/2072-6694/15/5/1364

“Predicting Lymph Node Metastasis Status from Primary Muscle-Invasive Bladder Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study”
by Qingyuan Zheng, Jun Jian, Jingsong Wang, Kai Wang, Junjie Fan, Huazhen Xu, Xinmiao Ni, Song Yang, Jingping Yuan, Jiejun Wu et al.
Cancers 2023, 15(11), 3000; https://doi.org/10.3390/cancers15113000
Available online: https://www.mdpi.com/2072-6694/15/11/3000

“Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival”
by Hubert Kamecki, Małgorzata Dębowska, Jan Poleszczuk, Tomasz Demkow, Artur Przewor, Łukasz Nyk and Roman Sosnowski
Cancers 2023, 15(3), 668; https://doi.org/10.3390/cancers15030668
Available online: https://www.mdpi.com/2072-6694/15/3/668

“P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer”
by Stephan Ledderose, Severin Rodler, Lennert Eismann, Georg Ledderose, Martina Rudelius, Wolfgang G. Junger and Carola Ledderose
Cancers 2023, 15(8), 2321; https://doi.org/10.3390/cancers15082321
Available online: https://www.mdpi.com/2072-6694/15/8/2321

“Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway”
by Yuhang Zhang, Wenyu Wang, Hang Zhou and Yimin Cui
Cancers 2023, 15(3), 809; https://doi.org/10.3390/cancers15030809
Available online: https://www.mdpi.com/2072-6694/15/3/809

“Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation”
by Sébastien Meunier, Alexandre Frontczak, Loïc Balssa, Julie Blanc, Salim Benhmida, Mandy Pernot, Magali Quivrin, Etienne Martin, Yasser Hammoud, Gilles Créhange et al.
Cancers 2023, 15(6), 1886; https://doi.org/10.3390/cancers15061886
Available online: https://www.mdpi.com/2072-6694/15/6/1886

“Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry”
by Christoph Pöttgen, Christian Hoffmann, Thomas Gauler, Maja Guberina, Nika Guberina, Toke Ringbaek, Alina Santiago Garcia, Ulrich Krafft, Boris Hadaschik, Aymane Khouya et al.
Cancers 2023, 15(20), 4933; https://doi.org/10.3390/cancers15204933
Available online: https://www.mdpi.com/2072-6694/15/20/4933

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer immunology and immunotherapy in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special issue can be seen below.

You are invited to view and submit relevant papers, proposals for some related special issues to the journal Cancers at the following links:

• https://www.mdpi.com/journal/cancers;
• https://www.mdpi.com/journalproposal/sendproposalspecialissue/cancers.

Cancers Editorial Office

May is designated as “Brain Tumor Awareness Month”, with various global activities that highlight and increase awareness of brain tumors for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of brain tumors, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers is provided below:                                   

“Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model”
by Hideki Kashiwagi, Yoshihide Hattori, Shinji Kawabata, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Hiroyuki Shiba, Ryo Hiramatsu, Toshihiro Takami et al.
Cancers 2023, 15(4), 1034; https://doi.org/10.3390/cancers15041034
Available online: https://www.mdpi.com/2072-6694/15/4/1034

“Modeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells”
by Zahraa I. Khamis, Drishty B. Sarker, Yu Xue, Nancy Al-Akkary, Viviana D. James, Changchun Zeng, Yan Li and Qing-Xiang Amy Sang
Cancers 2023, 15(4), 1253; https://doi.org/10.3390/cancers15041253
Available online: https://www.mdpi.com/2072-6694/15/4/1253

“Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials”
by Ruman Rahman, Miroslaw Janowski, Clare L. Killick-Cole, William G. B. Singleton, Emma Campbell, Piotr Walczak, Soumen Khatua, Lukas Faltings, Marc Symons, Julia R. Schneider et al.
Cancers 2023, 15(3), 857; https://doi.org/10.3390/cancers15030857
Available online: https://www.mdpi.com/2072-6694/15/3/857

“Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors”
by Nandita Saha, Andre Kuehne, Jason M. Millward, Thomas Wilhelm Eigentler, Ludger Starke, Sonia Waiczies and Thoralf Niendorf
Cancers 2023, 15(8), 2303; https://doi.org/10.3390/cancers15082303
Available online: https://www.mdpi.com/2072-6694/15/8/2303

“Efficient Brain Tumor Detection with Lightweight End-to-End Deep Learning Model”
by Mohamed Hammad, Mohammed ElAffendi, Abdelhamied A. Ateya and  Ahmed A. Abd El-Latif
Cancers 2023, 15(10), 2837; https://doi.org/10.3390/cancers15102837
Available online: https://www.mdpi.com/2072-6694/15/10/2837

“Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor”
by Elisa Scola, Guido Del Vecchio, Giorgio Busto, Andrea Bianchi, Ilaria Desideri, Davide Gadda, Sara Mancini, Edoardo Carlesi, Marco Moretti, Isacco Desideri et al.
Cancers 2023, 15(11), 2992; https://doi.org/10.3390/cancers15112992
Available online: https://www.mdpi.com/2072-6694/15/11/2992

“Mapping Resection Progress by Tool-Tip Tracking during Brain Tumor Surgery for Real-Time Estimation of Residual Tumor”
by Parikshit Juvekar, Erickson Torio, Wenya Linda Bi, Dhiego Chaves De Almeida Bastos, Alexandra J. Golby and Sarah F. Frisken
Cancers 2023, 15(3), 825; https://doi.org/10.3390/cancers15030825
Available online: https://www.mdpi.com/2072-6694/15/3/825

“Imaging the WHO 2021 Brain Tumor Classification: Fully Automated Analysis of Imaging Features of Newly Diagnosed Gliomas”
by Michael Griessmair, Claire Delbridge, Julian Ziegenfeuter, Denise Bernhardt, Jens Gempt, Friederike Schmidt-Graf, Olivia Kertels, Marie Thomas, Hanno S. Meyer, Claus Zimmer et al.
Cancers 2023, 15(8), 2355; https://doi.org/10.3390/cancers15082355
Available online: https://www.mdpi.com/2072-6694/15/8/2355

“A Fully Automated Post-Surgical Brain Tumor Segmentation Model for Radiation Treatment Planning and Longitudinal Tracking”
by Karthik K. Ramesh, Karen M. Xu, Anuradha G. Trivedi, Vicki Huang, Vahid Khalilzad Sharghi, Lawrence R. Kleinberg, Eric A. Mellon, Hui-Kuo G. Shu, Hyunsuk Shim and Brent D. Weinberg
Cancers 2023, 15(15), 3956; https://doi.org/10.3390/cancers15153956
Available online: https://www.mdpi.com/2072-6694/15/15/3956

“Radiomics and Machine Learning in Brain Tumors and Their Habitat: A Systematic Review”
by Mehnaz Tabassum, Abdulla Al Suman, Eric Suero Molina, Elizabeth Pan, Antonio Di Ieva and Sidong Liu
Cancers 2023, 15(15), 3845; https://doi.org/10.3390/cancers15153845
Available online: https://www.mdpi.com/2072-6694/15/15/3845

“Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B”
by Natasha Pillay-Smiley, James Leach, Adam Lane, Trent Hummel, Jason Fangusaro and Peter de Blank
Cancers 2023, 15(7), 2109; https://doi.org/10.3390/cancers15072109
Available online: https://www.mdpi.com/2072-6694/15/7/2109

“Intraoperative Imaging and Optical Visualization Techniques for Brain Tumor Resection: A Narrative Review”
by Othman Bin-Alamer, Hussam Abou-Al-Shaar, Zachary C. Gersey, Sakibul Huq, Justiss A. Kallos, David J. McCarthy, Jeffery R. Head, Edward Andrews, Xiaoran Zhang and Constantinos G. Hadjipanayis
Cancers 2023, 15(19), 4890; https://doi.org/10.3390/cancers15194890
Available online: https://www.mdpi.com/2072-6694/15/19/4890

“Cognitive Sparing in Proton versus Photon Radiotherapy for Pediatric Brain Tumor Is Associated with White Matter Integrity: An Exploratory Study”
by Lisa E. Mash, Lisa S. Kahalley, Kimberly P. Raghubar, Naomi J. Goodrich-Hunsaker, Tracy J. Abildskov, Luz A. De Leon, Marianne MacLeod, Heather Stancel, Kelley Parsons, Brian Biekman et al.
Cancers 2023, 15(6), 1844; https://doi.org/10.3390/cancers15061844
Available online: https://www.mdpi.com/2072-6694/15/6/1844

“Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors”
by Mathieu Chicard, Yasmine Iddir, Julien Masliah Planchon, Valérie Combaret, Valéry Attignon, Alexandra Saint-Charles, Didier Frappaz, Cécile Faure-Conter, Kévin Beccaria, Pascale Varlet et al.
Cancers 2023, 15(13), 3532; https://doi.org/10.3390/cancers15133532
Available online: https://www.mdpi.com/2072-6694/15/13/3532

“Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review”
by Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, Nitin R. Wadhawani, Craig Horbinski, Matthew McCord, Alicia C. Lenzen, Amy B. Heimberger and Michael DeCuypere
Cancers 2023, 15(14), 3655; https://doi.org/10.3390/cancers15143655
Available online: https://www.mdpi.com/2072-6694/15/14/3655

“Proteomic Analysis on Sequential Samples of Cystic Fluid Obtained from Human Brain Tumors”
by Lorenzo Magrassi, Francesca Brambilla, Raffaello Viganò, Dario Di Silvestre, Louise Benazzi, Giuseppe Bellantoni, Gian Marco Danesino, Sergio Comincini and Pierluigi Mauri
Cancers 2023, 15(16), 4070; https://doi.org/10.3390/cancers15164070
Available online: https://www.mdpi.com/2072-6694/15/16/4070

“Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging”
by Nastaran Khalili,  Hossein Shooli, Nastaran Hosseini, Anahita Fathi Kazerooni, Ariana Familiar, Sina Bagheri, Hannah Anderson, Stephen J. Bagley and Ali Nabavizadeh
Cancers 2023, 15(21), 5198; https://doi.org/10.3390/cancers15215198
Available online: https://www.mdpi.com/2072-6694/15/21/5198

“RFS+: A Clinically Adaptable and Computationally Efficient Strategy for Enhanced Brain Tumor Segmentation”
by Abdulkerim Duman, Oktay Karakuş, Xianfang Sun, Solly Thomas, James Powell and Emiliano Spezi
Cancers 2023, 15(23), 5620; https://doi.org/10.3390/cancers15235620
Available online: https://www.mdpi.com/2072-6694/15/23/5620

“Evaluation of a Balloon Implant for Simultaneous Magnetic Nanoparticle Hyperthermia and High-Dose-Rate Brachytherapy of Brain Tumor Resection Cavities”
by Shuying Wan, Dario B. Rodrigues, Janet Kwiatkowski, Omaditya Khanna, Kevin D. Judy, Robert C. Goldstein, Marty Overbeek Bloem, Yan Yu, Sophia E. Rooks, Wenyin Shi et al.
Cancers 2023, 15(23), 5683; https://doi.org/10.3390/cancers15235683
Available online: https://www.mdpi.com/2072-6694/15/23/5683

“MRI-Based Assessment of Brain Tumor Hypoxia: Correlation with Histology”
By Fatemeh Arzanforoosh, Maaike Van der Velden, Avery J. L. Berman, Sebastian R. Van der Voort, Eelke M. Bos, Joost W. Schouten, Arnaud J. P. E. Vincent, Johan M. Kros, Marion Smits and Esther A. H. Warnert
Cancers 2024, 16(1), 138; https://doi.org/10.3390/cancers16010138
Available online: https://www.mdpi.com/2072-6694/16/1/138

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.

Prize:

• CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
• An award medal for each winner.

Who should be nominated?

• Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Who can submit a nomination?

• Academic research institutes
• Universities
• Academic societies

Any personal nominations are not accepted.

How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.

Required nomination materials:
Nomination Form (Download)

Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.

Contact:
Tu Youyou Award Team (tuyouyouaward@mdpi.com)

More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.

MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.

The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.

On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.

Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.

Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.

MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.

We are thrilled to share the updated Exceptional Reviewers List 2024. This program was designed to recognize scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role that our reviewers play in maintaining the quality and integrity of the articles that we publish. According to surveys conducted in 2023, 91% of our authors rate the peer-review process as good or excellent, which is thanks to our pool of excellent reviewers.

We wish to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback and contributing to academic rigor, are truly commendable.

The Exceptional Reviewers List was introduced in April 2024. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here.

Q1

Name: Dr. Muhammad Kibriya
Affiliation: Institute for Population and Precision Health (IPPH), Biological Sciences Division, University of Chicago, Chicago, IL, USA
Interests: colorectal carcinoma; microsatellite instability; cytogenetics; molecular genomics; GWAS; copy number change; telomere; methylation; liquid biopsy

Name: Dr. Matthias Nees
Affiliation: Department of Biochemistry and Molecular Biology, Medical University in Lublin, Lublin, Poland
Interests: organotypic culture; tumor/stroma interactions; 3D models; extracellular matrix (ECM); tumour microenvironment (TME); epithelial-to-mesenchymal transition (EMT); automated image analyses; phenotypic screening; personalized medicine

Name: Dr. Laura Casalino
Affiliation: Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, Consiglio Nazionale dele Ricerche (CNR), Naples, Italy
Interests: cell differentiation; development; stem cells; transcription factors; epigenetics

Name: Dr. Antonella Argentiero
Affiliation: Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Bari, Italy
Interests: pancreatic cancer; pancreatic ductal adenocarcinoma; tumor microenvironment

Name: Dr. John T. Lucas, Jr.
Affiliation: St. Jude Children’s Research Hospital, Memphis, TN, USA
Interests: neuroblastoma; high grade glioma; proteomics; clinical trial design/methodology

Q2:

Name: Prof. Dr. Laura Salter Kubatko
Affiliation: Department of Evolution, Ecology and Organismal Biology, The Ohio State University, Columbus, OH 43210, USA
Interests: statistical genetics; phylogenetics; population genetics; computational biology; statistical education

Name: Dr. Bethany N. Smith
Affiliation: Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Interests: role of androgen signaling in prostate cancer; microenvironment; cancer metabolism

Name: Prof. Dr. Antonio Maccio
Affiliation: Department of Gynecologic Oncology, ARNAS G. Brotzu and Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
Interests: ovarian cancer; laparoscopic surgery; immune system and immunotherapy; inflammation; macrophages; cytokines; cancer cachexia; cancer-related anemia

Name: Dr. Theo Kantidakis
Affiliation: Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK
Interests: tRNA; kmt2d; mll2; chromatin; RNA Polymerase III; genomic instability; RNA Polymerase II; cancer; rna-seq; aminoacyl-trna synthetase; mll3; KMT2C

Name: Dr. Tariq Bhat
Affiliation: Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA
Interests: immune dysfunction in infections and cancer; prostate cancer; bladder cancer; microbial dysbiosis in cancer; tumor Immunology; immunometabolism and antitumor immunity

Q3:

Name: Dr. Luca Fagnocchi
Affiliation: Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA
Interests: bioinformatics; epigenetics; molecular biology; gene regulation

Name: Dr. Mohammed L. Abba
Affiliation:Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
Interests: oncology; translational cancer research; microRNA

Name: Dr. Karin Wallander
Affiliation: Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
Interests: sarcoma; genomics; transcriptomics

Name: Dr. Josep Baulida
Affiliation: Hospital del Mar Research Institute (IMIM), Barcelona, Spain
Interests: molecular mechanisms that regulate pro-metastatic tumor stroma; transcriptomics; snai1 gene

Name: Dr. Paolo Emidio Costantini 
Affiliation: Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum, Università di Bologna, Via Francesco Selmi 3, Bologna, 40126, Italy
Interests: microbiology; molecular biology

Q4:

Name: Dr. Amit K. Maiti
Affiliation: Department of Genetics and Genomics, Mydnavar, 2645 Somerset Boulevard, Troy, MI 48084, USA
Interests: lymphomas; radiation oncology

Name: Dr. Michael S. Jackson
Affiliation: Newcastle University, United Kingdom, Institute of Genetic Medicine, Newcastle, United Kingdom
Interests: circular RNA; genome instability; cancer

Name: Dr. Marta Maria Falcão Estrada
Affiliation: Champalimaud Centre of the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal
Interests: breast cancer; ovarian cancer; translational research in oncology; in vitro/ex vivo 3D complex models; zebrafish xenograft models

Name: Dr. Jeremie Vitte
Affiliation: Department of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA
Interests: tumor predisposition syndromes; neuro-oncology; neurofibromatosis type 2; schwannomatosis; rhabdoid tumor predisposition syndrome; pre-clinical research

Name: Dr. Francesco Bianconi
Affiliation: Department of Engineering, Università degli Studi di Perugia, Via Goffredo Duranti 93–06125 Perugia (PG), Italy
Interests: artificial intelligence; computational imaging; computer vision; image processing; medical image analysis; radiomics
“Reviewing papers helps me to keep up with the latest advancements in my field.”

Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to tumor microenvironment, a curated list of high-quality articles from 2022 to 2023 Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.

The list of relevant papers can be seen below:

“Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy”
by Leah Davis, Matthias Recktenwald, Evan Hutt, Schuyler Fuller, Madison Briggs, Arnav Goel and Nichole Daringer
Cancers 2022, 14(5), 1259; https://doi.org/10.3390/cancers14051259
Available online: https://www.mdpi.com/2072-6694/14/5/1259

“Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer”
by Tomohiko Shinkawa, Kenoki Ohuchida and Masafumi Nakamura
Cancers 2022, 14(16), 3994; https://doi.org/10.3390/cancers14163994
Available online: https://www.mdpi.com/2072-6694/14/16/3994

“Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment”
by Naji Kharouf, Thomas W. Flanagan, Sofie-Yasmin Hassan, Hosam Shalaby, Marla Khabaz, Sarah-Lilly Hassan, Mosaad Megahed, Youssef Haikel, Simeon Santourlidis and Mohamed Hassan
Cancers 2023, 15(12), 3147; https://doi.org/10.3390/cancers15123147
Available online: https://www.mdpi.com/2072-6694/15/12/3147

“Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy”
by Alison K. Buxton, Salma Abbasova, Charlotte L. Bevan and Damien A. Leach
Cancers 2022, 14(24), 6189; https://doi.org/10.3390/cancers14246189
Available online: https://www.mdpi.com/2072-6694/14/24/6189

“PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies”
by Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro and Gabriella Mincione
Cancers 2023, 15(11), 2923; https://doi.org/10.3390/cancers15112923
Available online: https://www.mdpi.com/2072-6694/15/11/2923

“Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment”
by V. A. Shiva Ayyadurai, Prabhakar Deonikar, Kevin G. McLure and Kathleen M. Sakamoto
Cancers 2022, 14(3), 756; https://doi.org/10.3390/cancers14030756
Available online: https://www.mdpi.com/2072-6694/14/3/756

“Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression”
by Janson Tse, Thomas Pierce, Annalisa L. E. Carli, Mariah G. Alorro, Stefan Thiem, Eric G. Marcusson, Matthias Ernst and Michael Buchert
Cancers 2022, 14(2), 264; https://doi.org/10.3390/cancers14020264
Available online: https://www.mdpi.com/2072-6694/14/2/264

“STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential”
by Sarah Q. To, Rhynelle S. Dmello, Anna K. Richards, Matthias Ernst and Ashwini L. Chand
Cancers 2022, 14(2), 429; https://doi.org/10.3390/cancers14020429
Available online: https://www.mdpi.com/2072-6694/14/2/429

“AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis”
by Marie-Anne Goyette and Jean-François Côté
Cancers 2022, 14(3), 466; https://doi.org/10.3390/cancers14030466
Available online: https://www.mdpi.com/2072-6694/14/3/466

“Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets”
by Ralf-Peter Czekay, Dong-Joo Cheon, Rohan Samarakoon, Stacie M. Kutz and Paul J. Higgins
Cancers 2022, 14(5), 1231; https://doi.org/10.3390/cancers14051231
Available online: https://www.mdpi.com/2072-6694/14/5/1231

“Impact of Lipid Metabolism on Antitumor Immune Response”
by Nesrine Mabrouk, Baptiste Lecoeur, Ali Bettaieb, Catherine Paul and Frédérique Végran
Cancers 2022, 14(7), 1850; https://doi.org/10.3390/cancers14071850
Available online: https://www.mdpi.com/2072-6694/14/7/1850

“Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context”
by Mannon Geindreau, Mélanie Bruchard and Frédérique Vegran
Cancers 2022, 14(10), 2446; https://doi.org/10.3390/cancers14102446
Available online: https://www.mdpi.com/2072-6694/14/10/2446

“The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated”
by Roumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, Isabelle Coste, Toufic Renno, Cédric Chaveroux, Nicolas Aznar and Stéphane Ansieau
Cancers 2022, 14(11), 2793; https://doi.org/10.3390/cancers14112793
Available online: https://www.mdpi.com/2072-6694/14/11/2793

“The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens”
by Sukrit Mahajan, Mirko H. H. Schmidt  and Ulrike Schumann
Cancers 2023, 15(7), 2024; https://doi.org/10.3390/cancers15072024
Available online: https://www.mdpi.com/2072-6694/15/7/2024

“Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development”
by Valentina Bollati, Paola Monti, Davide Biganzoli, Giuseppe Marano, Chiara Favero, Simona Iodice, Luca Ferrari, Laura Dioni, Francesca Bianchi, Angela Cecilia Pesatori et al.
Cancers 2023, 15(17), 4317; https://doi.org/10.3390/cancers15174317
Available online: https://www.mdpi.com/2072-6694/15/17/4317

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office